Skip to main content
Search
Main Navigation
Home
News
Current Index
Topics
Research leaders
Supplements
Further analysis
Client
services
About
×
Search category
Institutions
Countries/territories
Topics
Article
Search
Search
Search
Search
Time frame: 1 May 2025 - 30 April 2026
Institution search supports local language names.
(Examples: Universidad Autónoma de Madrid
,
筑波大学)
View the latest institution rankings
View the latest Country/territory rankings
View topics
Home
Articles
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.
Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer.
Journal:
Journal of Clinical Oncology
Published:
2025-06-03
DOI
:
10.1200/jco-25-00883
Affiliations:
35
Authors:
124
Go to article
Institutions
Authors
Share
AstraZeneca, United Kingdom (UK)
2.000000
0.07
Taipei Medical University Shuang Ho Hospital (SHH), Taiwan
1.000000
0.04
Hanoi Oncology Hospital, Vietnam
1.000000
0.04
Korea University Guro Hospital, South Korea
1.000000
0.04
Pusan National University Yangsan Hospital (PNUYH), South Korea
1.000000
0.04
National Cancer Center Hospital East, Japan
1.000000
0.04
Vall d'Hebron University Hospital (HUVH), ICS, Spain
1.000000
0.04
Shandong Cancer Hospital, China
1.000000
0.04
Yale University, United States of America (USA)
1.000000
0.04
Kanagawa Cancer Center, Japan
1.000000
0.04
Chiang Mai University (CMU), Thailand
1.000000
0.04
State Key Laboratory of Respiratory Disease (SKLRD), China
1.000000
0.04
Klinik Floridsdorf, Austria
1.000000
0.04
AstraZeneca Gaithersburg, MD, United States of America (USA)
1.000000
0.04
State Key Laboratory of Molecular Oncology, China
1.000000
0.04
Orlandi Oncología, Chile
1.000000
0.04
National Taiwan University Hospital (NTUH), Taiwan
1.000000
0.04
National Cancer Center (NCC), Japan
1.000000
0.04
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China
1.000000
0.04
Hospital Alemão Oswaldo Cruz, Brazil
1.000000
0.04
University of Zurich (UZH), Switzerland
0.500000
0.02
Privatklinik Bethanien, Switzerland
0.500000
0.02
The Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom (UK)
0.500000
0.02
UCSF Health, United States of America (USA)
0.500000
0.02
University of Liverpool, United Kingdom (UK)
0.500000
0.02
National Lung Hospital, Vietnam
0.500000
0.02
Vietnam National University, Hanoi (VNU), Vietnam
0.500000
0.02
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)
0.500000
0.02
Weill Cornell Medicine, United States of America (USA)
0.500000
0.02
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
0.500000
0.02
Sichuan Cancer Hospital, China
0.500000
0.02
University of Electronic Science and Technology of China (UESTC), China
0.500000
0.02
Interested in
Oncology and Carcinogenesis
?
News
News home
News
Comment
Data insights
Dataviz
Careers
Q+A
Archive
Current Index
Institution rankings
Institution benchmarking
Institution collaboration
Country/territory rankings
Country/territory benchmarking
Country/territory collaboration
Data visualizations
Articles
Research highlights
Data products survey
Topics
Topic explorer
Nature Index topics
Leading institutions by topic
Leading countries/territories by topic
Research leaders
Research leaders home
2026 Research Leaders
2025 Research Leaders
2024 Research Leaders
2023 Research Leaders
2022 Research Leaders
2021 Research Leaders
2020 Research Leaders
2019 Research Leaders
2018 Research Leaders
2017 Research Leaders
2016 Research Leaders
Supplements
Nature Index supplements
Further analysis
Author gender ratio
Applied sciences
Nature Strategy Reports
Client services
Client services
Advertising
Research management
Brochure
About
Mission statement
A brief guide to the Nature Index
How to use the Nature Index
FAQ
About Nature Research Intelligence Topics
Institutions A-Z
Glossary of terms
Follow us on Twitter
Follow us on Facebook